A Form 4 filed on September 10, 2026, disclosed that Lu Peng, President of Pharvaris N.V. (NASDAQ:PHVS), exercised stock options and sold 15,000 shares of common stock on September 8, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Lu Peng acquired 15,000 shares of common stock on September 8, 2026, via a stock option exercise (transaction code M) at a price of $2.59 per share.
  • Shares sold: 15,000 shares were sold on September 8, 2026 (transaction code S) at a weighted average price of $40.6756, with individual sale prices ranging from $40.50 to $40.80.
  • Post-transaction ownership: Following the transactions, Peng directly beneficially owned 65,179 shares of common stock.
  • 10b5-1 plan: The filing states the exercise and sale were scheduled transactions executed pursuant to a Rule 10b5-1 trading plan.
  • Remaining options: Peng holds 43,308 stock options with an exercise price of $2.59, expiring February 3, 2030, directly owned.
  • Cashless exercise: According to the filing, the shares were sold in connection with the option exercise in a cashless exercise transaction.

Pharvaris President Executes Scheduled Option Exercise and Sale

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Lu Peng, President of Pharvaris N.V. (NASDAQ:PHVS), reported two linked transactions on September 8, 2026. Peng first exercised stock options to acquire 15,000 shares of common stock at an exercise price of $2.59 per share, bringing beneficial ownership at that point to 80,179 shares held directly. The options were granted with 25% vesting on February 3, 2021, and the remainder vesting in 1/48 monthly installments thereafter, with an expiration date of February 3, 2030.

Immediately following the exercise, the filing reports that 15,000 shares were sold in multiple transactions at prices ranging from $40.50 to $40.80, with a weighted average sale price of $40.6756. The filing characterizes this as a cashless exercise transaction carried out under a pre-established Rule 10b5-1 trading plan. After both transactions, Peng's direct beneficial ownership of common stock stood at 65,179 shares. The filing also notes that Peng retains 43,308 stock options directly.

The Form 4 was signed by Marnus Nel as Attorney-in-Fact for Peng Lu and dated September 10, 2026. The filing notes that full information on the number of shares sold at each separate price will be provided to the issuer, any security holder, or SEC staff upon request.

What Was Disclosed

Pharvaris N.V. President Lu Peng filed a Form 4 reporting the September 8, 2026, exercise of 15,000 stock options at $2.59 and the same-day sale of 15,000 shares at a weighted average price of $40.6756, both executed under a Rule 10b5-1 plan.